Home >
Medicine Info >
K-Stat ET Tablet
Loading interface...

K-Stat ET Tablet

Manufactured byMERCURY LABORATORIES LTD
ContainsEthamsylate (250 mg) + Tranexamic Acid (500 mg)
Description
K-Stat ET Tablet is a combination medicine that consists of Tranexamic acid and Ethamsylate. It is used for the treatment of prolonged or heavy menstrual bleeding. This medicine prevents the breakdown of blood clots in your body and also increases the ability of platelets to stick together and helps in the formation of blood clots. Thus, K-Stat ET Tablet effectively control excessive bleeding. K-Stat ET Tablet shows common side effects like nausea, stomach pain, headache, and joint pain. It may also cause diarrhoea in some people. Drink plenty of water to prevent dehydration if you experience diarrhoea. Consult your doctor at the earliest if any of these side effects persist or worsen. Avoid taking this medicine if you are allergic to it. K-Stat ET Tablet is not recommended for use in children under 18 years of age. K-Stat ET Tablet can be taken with or without food. Take this medicine at the same time every day as prescribed by your doctor and do not change the dose and frequency on your own. Do not stop using this medicine suddenly without consulting your doctor. Consult your doctor if you do not notice any improvement in 3 consecutive periods. K-Stat ET Tablet can impact the action of other medicines. Inform your doctor if you have any other medical conditions such as kidney or heart problems, porphyria, bleeding disorder, etc. and also your ongoing medicines. Inform your doctor if you are pregnant, planning a pregnancy or breastfeeding before taking this medicine. Your doctor may monitor your clotting or bleeding time and advise eye checkups for safety aspects.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for K-Stat ET Tablet

  • Nasal discharge
  • Back pain
  • Pale skin
  • Muscle or joint pain
  • Unusual tiredness and weakness
  • Change in color vision
  • Difficulty in breathing
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Pain in the chest region
  • Dizziness and fainting
  • Presence of blood in cough
  • Severe allergic reaction
  • High fever
  • Headache
  • Skin rash
  • Nausea
  • Stomach pain
  • Diarrhoea

Uses of K-Stat ET Tablet

What is it prescribed for?

  • Menorrhagia
  • Post operative hemorrhage
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for K-Stat ET Tablet to start showing its effect is not known.
  • How long do the effects of this medicine last?
    The duration of action of K-Stat ET Tablet is about 6-8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No-habit forming tendencies were reported for K-Stat ET Tablet.
  • Can this medicine be taken during pregnancy?
    K-Stat ET Tablet is not recommended for use in pregnancy as it may harm your foetus. Hence, consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    It is not known whether K-Stat ET Tablet passes into breastmilk or not. Hence, consult your doctor before taking this medicine.

Allergy

Avoid taking K-Stat ET Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Acquired defective color vision

Acquired defective colour vision represents a group of conditions that affect the perception of colour. K-Stat ET Tablet is not recommended for use in people having defective colour vision since it may worsen the condition.

Subarachnoid hemorrhage

Subarachnoid haemorrhage is a serious condition characterized by bleeding in the outer layers of your brain. K-Stat ET Tablet is not recommended for use in such cases.

Obstructive blood clotting disorder

K-Stat ET Tablet is not recommended for use if you have obstructive clotting disorders due to the increased risk of worsening your condition.

Porphyria

Porphyria is a rare genetic disorder that mainly affects your skin or nervous system. This disorder is usually inherited, which means it is caused by gene mutations passed from parents to children. K-Stat ET Tablet is not recommended to use in this condition.

Fibroids

K-Stat ET Tablet is not recommended for use in women who have fibroids (abnormal growth in the uterus).
Warnings for special population

Pregnancy

K-Stat ET Tablet is not recommended for use in pregnancy as it may harm your foetus. Hence, consult your doctor before taking this medicine.

Breast-feeding

It is not known whether K-Stat ET Tablet passes into breastmilk or not. Hence, consult your doctor before taking this medicine.
General warnings

Use of hormonal contraceptives

K-Stat ET Tablet is not recommended for use in women using contraceptives (pills, patches, vaginal rings, or injections) since the risk of severe side effects is significantly high.

Clotting disorders

K-Stat ET Tablet should be avoided if you have a history of clotting disorders or have an active clotting disorder. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Eye disorders

K-Stat ET Tablet is not recommended for use if you have a history of any medical condition where the blood vessels of the eye are obstructed due to clot formation.

Fever

K-Stat ET Tablet may cause an increase in body temperature in some people. Contact your doctor immediately if you experience a high fever.

Other medicines

K-Stat ET Tablet may interact with many other medicines and cause severe side effects. Hence, it is advised that you report all your current medications to your doctor before beginning treatment with this medicine.

Use in Children

K-Stat ET Tablet is not recommended for use in children less than 18 years of age as the safety and efficacy data are not available.

Driving or operating machines

K-Stat ET Tablet may cause blurred vision or dizziness in some patients. Hence, avoid driving vehicles or operating machines after taking this medicine.

Missed Dose

If you forget to take a dose of K-Stat ET Tablet, make sure that you remember to take your next dose when it is due. Do not take two doses together to make up for the missed dose.

Overdose

Never take more than the prescribed dose. If you suspect that you might have taken an overdose of K-Stat ET Tablet, seek immediate medical treatment.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Tamoxifen

Ethinyl Estradiol

Tretinoin

Factor IX complex

Disease interactions

Kidney diseases

K-Stat ET Tablet should be used with caution if you have kidney problems. An impaired kidney leads to the accumulation of this medicine that may worsen the condition. Your doctor may monitor the kidney function and may adjust the dose based on your condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take K-Stat ET Tablet with or without food or as prescribed by your doctor. Do not take more or fewer doses than the prescribed quantity of this medicine. Stick to simple meals and avoid spicy rich food in order to avoid feeling sick. If you get diarrhoea while taking this medicine, consult your doctor immediately. Along with taking K-Stat ET Tablet, you can use a heating pad to get relief during periods. Inform your doctor if there is no improvement in your bleeding after using this medicine for three consecutive periods. Do not crush, break or chew K-Stat ET Tablet in the mouth. Take the tablet immediately after peeling it from the strip. Keep the medicine away from the reach of children and pets. Ensure that the unused or expired medicine is disposed of properly.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
K-Stat ET Tablet contains tranexamic acid and ethamsylate. Tranexamic acid works by preventing certain enzymes that break down a blood clot formed in the body. Ethamsylate acts by stabilizing the walls of the capillaries, increasing platelet aggregation to form clots. Thus it controls bleeding.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Miscellaneous coagulation modifiers, Hemostatics

Schedule

Schedule H

Drugs, H., 2021. Tranexamic Acid: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 9 August 2021].

https://medlineplus.gov/druginfo/meds/a612021.html>

2021. [online] Available at: < [Accessed 9 August 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022430s004lbl.pdf>

Taj Life Sciences. 2021. Tranexamic Acid Tablets BP. 250mg. [online] Available at: < [Accessed 9 August 2021].

https://tajlifesciences.com/portfolio/tranexamic-acid-tablets-bp-250mg/>

Pubchem.ncbi.nlm.nih.gov. 2021. Etamsylate. [online] Available at: < [Accessed 9 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/17506#section=EMA-Drug-Information>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 Nov 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.